Europe eterinary Vaccines Market Research Report Forecast 2017-2021

March 2017 | 109 pages | ID: ED1692D1579EN
S&P Consulting

Abstracts

The Europe eterinary Vaccines Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the eterinary Vaccines industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This eterinary Vaccines market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe eterinary Vaccines Market Analysis by Countries:

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

The Major players reported in the market include:
GE Healthcare
Bayer Healthcare
Boehringer Ingelheim
Ceva Animal Health
Elanco Animal Health (Eli Lilly)
Heska Corporation
Merck Animal Healthcare
Merial Inc. (SANOFI)
Virbac
Europe eterinary Vaccines Market Analysis by Product:
Live Vaccine
DNA Vaccine
Inactivated Vaccines
Europe eterinary Vaccines Market Analysis by Application:
Livestock
Poultry
Application 3

REASONS FOR BUYING THIS REPORT

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

Europe eterinary Vaccines Sales Market Report Forecast 2017-2021

1 ETERINARY VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of eterinary Vaccines
1.2 Classification of eterinary Vaccines
  1.2.1 Live Vaccine
  1.2.2 DNA Vaccine
  1.2.3 Inactivated Vaccines
1.3 Application of eterinary Vaccines
  1.3.2 Livestock
  1.3.3 Poultry
  1.3.4 Application
1.4 eterinary Vaccines Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of eterinary Vaccines (2012-2021)
  1.5.1 Europe eterinary Vaccines Sales and Growth Rate (2012-2021)
  1.5.2 Europe eterinary Vaccines Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON ETERINARY VACCINES INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 ETERINARY VACCINES MANUFACTURING COST ANALYSIS

3.1 eterinary Vaccines Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of eterinary Vaccines

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 eterinary Vaccines Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of eterinary Vaccines Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE ETERINARY VACCINES MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe eterinary Vaccines Market Competition by Manufacturers
  5.1.1 Europe eterinary Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe eterinary Vaccines Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe eterinary Vaccines (Volume and Value) by Type
  5.2.1 Europe eterinary Vaccines Sales and Market Share by Type (2012-2017)
  5.2.2 Europe eterinary Vaccines Revenue and Market Share by Type (2012-2017)
5.3 Europe eterinary Vaccines (Volume and Value) by Countries
  5.3.1 Europe eterinary Vaccines Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe eterinary Vaccines Revenue and Market Share by Countries (2012-2017)
5.4 Europe eterinary Vaccines (Volume) by Application

6 GERMANY ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Germany eterinary Vaccines Sales and Value (2012-2017)
  6.1.1 Germany eterinary Vaccines Sales and Growth Rate (2012-2017)
  6.1.2 Germany eterinary Vaccines Revenue and Growth Rate (2012-2017)
  6.1.3 Germany eterinary Vaccines Sales Price Trend (2012-2017)
6.2 Germany eterinary Vaccines Sales and Market Share by Manufacturers
6.3 Germany eterinary Vaccines Sales and Market Share by Type
6.4 Germany eterinary Vaccines Sales and Market Share by Application

7 FRANCE ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 France eterinary Vaccines Sales and Value (2012-2017)
  7.1.1 France eterinary Vaccines Sales and Growth Rate (2012-2017)
  7.1.2 France eterinary Vaccines Revenue and Growth Rate (2012-2017)
  7.1.3 France eterinary Vaccines Sales Price Trend (2012-2017)
7.2 France eterinary Vaccines Sales and Market Share by Manufacturers
7.3 France eterinary Vaccines Sales and Market Share by Type
7.4 France eterinary Vaccines Sales and Market Share by Application

8 UK ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 UK eterinary Vaccines Sales and Value (2012-2017)
  8.1.1 UK eterinary Vaccines Sales and Growth Rate (2012-2017)
  8.1.2 UK eterinary Vaccines Revenue and Growth Rate (2012-2017)
  8.1.3 UK eterinary Vaccines Sales Price Trend (2012-2017)
8.2 UK eterinary Vaccines Sales and Market Share by Manufacturers
8.3 UK eterinary Vaccines Sales and Market Share by Type
8.4 UK eterinary Vaccines Sales and Market Share by Application

9 RUSSIA ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Russia eterinary Vaccines Sales and Value (2012-2017)
  9.1.1 Russia eterinary Vaccines Sales and Growth Rate (2012-2017)
  9.1.2 Russia eterinary Vaccines Revenue and Growth Rate (2012-2017)
  9.1.3 Russia eterinary Vaccines Sales Price Trend (2012-2017)
9.2 Russia eterinary Vaccines Sales and Market Share by Manufacturers
9.3 Russia eterinary Vaccines Sales and Market Share by Type
9.4 Russia eterinary Vaccines Sales and Market Share by Application

10 ITALY ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

10.1 Italy eterinary Vaccines Sales and Value (2012-2017)
  10.1.1 Italy eterinary Vaccines Sales and Growth Rate (2012-2017)
  10.1.2 Italy eterinary Vaccines Revenue and Growth Rate (2012-2017)
  10.1.3 Italy eterinary Vaccines Sales Price Trend (2012-2017)
10.2 Italy eterinary Vaccines Sales and Market Share by Manufacturers
10.3 Italy eterinary Vaccines Sales and Market Share by Type
10.4 Italy eterinary Vaccines Sales and Market Share by Application

11 SPAIN ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

11.1 Spain eterinary Vaccines Sales and Value (2012-2017)
  11.1.1 Spain eterinary Vaccines Sales and Growth Rate (2012-2017)
  11.1.2 Spain eterinary Vaccines Revenue and Growth Rate (2012-2017)
  11.1.3 Spain eterinary Vaccines Sales Price Trend (2012-2017)
11.2 Spain eterinary Vaccines Sales and Market Share by Manufacturers
11.3 Spain eterinary Vaccines Sales and Market Share by Type
11.4 Spain eterinary Vaccines Sales and Market Share by Application

12 BENELUX ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux eterinary Vaccines Sales and Value (2012-2017)
  12.1.1 Benelux eterinary Vaccines Sales and Growth Rate (2012-2017)
  12.1.2 Benelux eterinary Vaccines Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux eterinary Vaccines Sales Price Trend (2012-2017)
12.2 Benelux eterinary Vaccines Sales and Market Share by Manufacturers
12.3 Benelux eterinary Vaccines Sales and Market Share by Type
12.4 Benelux eterinary Vaccines Sales and Market Share by Application

13 EUROPE ETERINARY VACCINES MANUFACTURERS ANALYSIS

13.1 GE Healthcare
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Bayer Healthcare
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Boehringer Ingelheim
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Ceva Animal Health
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Elanco Animal Health (Eli Lilly)
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Heska Corporation
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Merck Animal Healthcare
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Merial Inc. (SANOFI)
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Virbac
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE ETERINARY VACCINES MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe eterinary Vaccines Market Forecast by Type (2017-2021)
15.9 Europe eterinary Vaccines Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of eterinary Vaccines
Table Classification of eterinary Vaccines
Figure Europe Sales Market Share of eterinary Vaccines by Type in 2015
Table Application of eterinary Vaccines
Figure Europe Sales Market Share of eterinary Vaccines by Application in 2015
Figure Germany eterinary Vaccines Revenue and Growth Rate (2012-2021)
Figure France eterinary Vaccines Revenue and Growth Rate (2012-2021)
Figure UK eterinary Vaccines Revenue and Growth Rate (2012-2021)
Figure Russia eterinary Vaccines Revenue and Growth Rate (2012-2021)
Figure Italy eterinary Vaccines Revenue and Growth Rate (2012-2021)
Figure Spain eterinary Vaccines Revenue and Growth Rate (2012-2021)
Figure Benelux eterinary Vaccines Revenue and Growth Rate (2012-2021)
Figure Europe eterinary Vaccines Sales and Growth Rate (2012-2021)
Figure Europe eterinary Vaccines Revenue and Growth Rate (2012-2021)
Table Europe eterinary Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Europe eterinary Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 eterinary Vaccines Sales Share by Manufacturers
Figure 2016 eterinary Vaccines Sales Share by Manufacturers
Table Europe eterinary Vaccines Revenue by Manufacturers (2015 and 2016)
Table Europe eterinary Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe eterinary Vaccines Revenue Share by Manufacturers
Table 2016 Europe eterinary Vaccines Revenue Share by Manufacturers
Table Europe eterinary Vaccines Sales and Market Share by Type (2012-2017)
Table Europe eterinary Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of eterinary Vaccines by Type (2012-2017)
Figure Europe eterinary Vaccines Sales Growth Rate by Type (2012-2017)
Table Europe eterinary Vaccines Revenue and Market Share by Type (2012-2017)
Table Europe eterinary Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of eterinary Vaccines by Type (2012-2017)
Figure Europe eterinary Vaccines Revenue Growth Rate by Type (2012-2017)
Table Europe eterinary Vaccines Sales and Market Share by Countries (2012-2017)
Table Europe eterinary Vaccines Sales Share by Countries (2012-2017)
Figure Sales Market Share of eterinary Vaccines by Countries (2012-2017)
Table Europe eterinary Vaccines Revenue and Market Share by Countries (2012-2017)
Table Europe eterinary Vaccines Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of eterinary Vaccines by Countries (2012-2017)
Table Europe eterinary Vaccines Sales and Market Share by Application (2012-2017)
Table Europe eterinary Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of eterinary Vaccines by Application (2012-2017)
Figure Germany eterinary Vaccines Sales and Growth Rate (2012-2017)
Figure Germany eterinary Vaccines Revenue and Growth Rate (2012-2017)
Figure Germany eterinary Vaccines Sales Price Trend (2012-2017)
Table Germany eterinary Vaccines Sales by Manufacturers (2015 and 2016)
Table Germany eterinary Vaccines Market Share by Manufacturers (2015 and 2016)
Table Germany eterinary Vaccines Sales by Type (2015 and 2016)
Table Germany eterinary Vaccines Market Share by Type (2015 and 2016)
Table Germany eterinary Vaccines Sales by Application (2015 and 2016)
Table Germany eterinary Vaccines Market Share by Application (2015 and 2016)
Figure France eterinary Vaccines Sales and Growth Rate (2012-2017)
Figure France eterinary Vaccines Revenue and Growth Rate (2012-2017)
Figure France eterinary Vaccines Sales Price Trend (2012-2017)
Table France eterinary Vaccines Sales by Manufacturers (2015 and 2016)
Table France eterinary Vaccines Market Share by Manufacturers (2015 and 2016)
Table France eterinary Vaccines Sales by Type (2015 and 2016)
Table France eterinary Vaccines Market Share by Type (2015 and 2016)
Table France eterinary Vaccines Sales by Application (2015 and 2016)
Table France eterinary Vaccines Market Share by Application (2015 and 2016)
Figure UK eterinary Vaccines Sales and Growth Rate (2012-2017)
Figure UK eterinary Vaccines Revenue and Growth Rate (2012-2017)
Figure UK eterinary Vaccines Sales Price Trend (2012-2017)
Table UK eterinary Vaccines Sales by Manufacturers (2015 and 2016)
Table UK eterinary Vaccines Market Share by Manufacturers (2015 and 2016)
Table UK eterinary Vaccines Sales by Type (2015 and 2016)
Table UK eterinary Vaccines Market Share by Type (2015 and 2016)
Table UK eterinary Vaccines Sales by Application (2015 and 2016)
Table UK eterinary Vaccines Market Share by Application (2015 and 2016)
Figure Russia eterinary Vaccines Sales and Growth Rate (2012-2017)
Figure Russia eterinary Vaccines Revenue and Growth Rate (2012-2017)
Figure Russia eterinary Vaccines Sales Price Trend (2012-2017)
Table Russia eterinary Vaccines Sales by Manufacturers (2015 and 2016)
Table Russia eterinary Vaccines Market Share by Manufacturers (2015 and 2016)
Table Russia eterinary Vaccines Sales by Type (2015 and 2016)
Table Russia eterinary Vaccines Market Share by Type (2015 and 2016)
Table Russia eterinary Vaccines Sales by Application (2015 and 2016)
Table Russia eterinary Vaccines Market Share by Application (2015 and 2016)
Figure Italy eterinary Vaccines Sales and Growth Rate (2012-2017)
Figure Italy eterinary Vaccines Revenue and Growth Rate (2012-2017)
Figure Italy eterinary Vaccines Sales Price Trend (2012-2017)
Table Italy eterinary Vaccines Sales by Manufacturers (2015 and 2016)
Table Italy eterinary Vaccines Market Share by Manufacturers (2015 and 2016)
Table Italy eterinary Vaccines Sales by Type (2015 and 2016)
Table Italy eterinary Vaccines Market Share by Type (2015 and 2016)
Table Italy eterinary Vaccines Sales by Application (2015 and 2016)
Table Italy eterinary Vaccines Market Share by Application (2015 and 2016)
Figure Spain eterinary Vaccines Sales and Growth Rate (2012-2017)
Figure Spain eterinary Vaccines Revenue and Growth Rate (2012-2017)
Figure Spain eterinary Vaccines Sales Price Trend (2012-2017)
Table Spain eterinary Vaccines Sales by Manufacturers (2015 and 2016)
Table Spain eterinary Vaccines Market Share by Manufacturers (2015 and 2016)
Table Spain eterinary Vaccines Sales by Type (2015 and 2016)
Table Spain eterinary Vaccines Market Share by Type (2015 and 2016)
Table Spain eterinary Vaccines Sales by Application (2015 and 2016)
Table Spain eterinary Vaccines Market Share by Application (2015 and 2016)
Figure Benelux eterinary Vaccines Sales and Growth Rate (2012-2017)
Figure Benelux eterinary Vaccines Revenue and Growth Rate (2012-2017)
Figure Benelux eterinary Vaccines Sales Price Trend (2012-2017)
Table Benelux eterinary Vaccines Sales by Manufacturers (2015 and 2016)
Table Benelux eterinary Vaccines Market Share by Manufacturers (2015 and 2016)
Table Benelux eterinary Vaccines Sales by Type (2015 and 2016)
Table Benelux eterinary Vaccines Market Share by Type (2015 and 2016)
Table Benelux eterinary Vaccines Sales by Application (2015 and 2016)
Table Benelux eterinary Vaccines Market Share by Application (2015 and 2016)
Table GE Healthcare Basic Information List
Table GE Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GE Healthcare eterinary Vaccines Sales Market Share (2012-2017)
Table Bayer Healthcare Basic Information List
Table Bayer Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Healthcare eterinary Vaccines Sales Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim eterinary Vaccines Sales Market Share (2012-2017)
Table Ceva Animal Health Basic Information List
Table Ceva Animal Health eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ceva Animal Health eterinary Vaccines Sales Market Share (2012-2017)
Table Elanco Animal Health (Eli Lilly) Basic Information List
Table Elanco Animal Health (Eli Lilly) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Elanco Animal Health (Eli Lilly) eterinary Vaccines Sales Market Share (2012-2017)
Table Heska Corporation Basic Information List
Table Heska Corporation eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Heska Corporation eterinary Vaccines Sales Market Share (2012-2017)
Table Merck Animal Healthcare Basic Information List
Table Merck Animal Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Animal Healthcare eterinary Vaccines Sales Market Share (2012-2017)
Table Merial Inc. (SANOFI) Basic Information List
Table Merial Inc. (SANOFI) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merial Inc. (SANOFI) eterinary Vaccines Sales Market Share (2012-2017)
Table Virbac Basic Information List
Table Virbac eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Virbac eterinary Vaccines Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of eterinary Vaccines
Figure Manufacturing Process Analysis of eterinary Vaccines
Figure eterinary Vaccines Industrial Chain Analysis
Table Raw Materials Sources of eterinary Vaccines Major Manufacturers in 2015
Table Major Buyers of eterinary Vaccines
Table Distributors/Traders List
Figure Germany eterinary Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Germany eterinary Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure France eterinary Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure France eterinary Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure UK eterinary Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure UK eterinary Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Russia eterinary Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Russia eterinary Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Italy eterinary Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Italy eterinary Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Spain eterinary Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Spain eterinary Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux eterinary Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Benelux eterinary Vaccines Revenue and Growth Rate Forecast (2017-2021)
Table Europe eterinary Vaccines Sales Forecast by Type (2017-2021)
Table Europe eterinary Vaccines Sales Forecast by Application (2017-2021)